| scholarly article | Q13442814 |
| P50 | author | Sylvain Brisse | Q28870498 |
| Ad C Fluit | Q91425260 | ||
| Maurine Ada Leverstein-van Hall | Q121133250 | ||
| P2093 | author name string | Jan Verhoef | |
| Armand Paauw | |||
| Adrienne T A Box | |||
| P2860 | cites work | Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat | Q24550671 |
| beta-Lactamases in laboratory and clinical resistance | Q24669605 | ||
| Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri | Q33694083 | ||
| Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate | Q33752745 | ||
| Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes | Q33964258 | ||
| Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. | Q33972587 | ||
| Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18 | Q33980456 | ||
| Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae | Q33982790 | ||
| Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae | Q33983667 | ||
| Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). | Q34135508 | ||
| New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy | Q34192597 | ||
| Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms | Q34459151 | ||
| New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases | Q35117085 | ||
| Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure | Q35120519 | ||
| Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. | Q35133558 | ||
| Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae | Q35136019 | ||
| Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test. | Q36541997 | ||
| Ability of the VITEK 2 advanced expert system To identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. | Q39455190 | ||
| Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital | Q39465236 | ||
| Automated thermal cycling is superior to traditional methods for nucleotide sequencing of bla(SHV) genes. | Q39472406 | ||
| Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex | Q39665321 | ||
| Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. | Q40014335 | ||
| Genetics of extended-spectrum beta-lactamases | Q40569199 | ||
| Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin-resistant Klebsiella pneumoniae isolate | Q42725452 | ||
| Outer membrane protein change combined with co-existing TEM-1 and SHV-1 beta-lactamases lead to false identification of ESBL-producing Klebsiella pneumoniae | Q43627834 | ||
| Detection of beta-lactamase-mediated resistance | Q43649165 | ||
| Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases. | Q43785356 | ||
| Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests | Q43869460 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes | Q44436393 | ||
| Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting | Q45010857 | ||
| Comparative susceptibility of clinical isolates producing extended spectrum beta-lactamases to ceftibuten: effect of large inocula | Q45044472 | ||
| Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. | Q54105047 | ||
| Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. | Q54589161 | ||
| Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation | Q71434749 | ||
| Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC | Q73053414 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| automation | Q184199 | ||
| multiple drug resistance | Q643839 | ||
| P304 | page(s) | 3703-3711 | |
| P577 | publication date | 2002-10-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. | |
| P478 | volume | 40 |
| Q30986331 | A qPCR and multiplex pyrosequencing assay combined with automated data processing for rapid and unambiguous detection of ESBL-producers Enterobacteriaceae |
| Q34431957 | Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents |
| Q53773275 | Antibacterial resistance patterns of pediatric community-acquired urinary infection: Overview. |
| Q34427614 | Bacterial nanoscale cultures for phenotypic multiplexed antibiotic susceptibility testing |
| Q41939169 | Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases |
| Q33235526 | Detection and genotyping of SHV beta-lactamase variants by mass spectrometry after base-specific cleavage of in vitro-generated RNA transcripts |
| Q42799124 | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures |
| Q39762100 | Direct comparison of the BD phoenix system with the MicroScan WalkAway system for identification and antimicrobial susceptibility testing of Enterobacteriaceae and nonfermentative gram-negative organisms |
| Q35023326 | Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility |
| Q46670411 | Epidemiological surveillance cultures in antimicrobial-resistant bacteria causing nosocomial infection |
| Q28552042 | Epidemiology and Resistance Patterns of Bacterial and Fungal Colonization of Biliary Plastic Stents: A Prospective Cohort Study |
| Q40282607 | Evaluation of the BD PHOENIX automated microbiology system for detection of methicillin resistance in coagulase-negative staphylococci |
| Q44527938 | Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice. |
| Q38478132 | Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterobacteriaceae |
| Q37419949 | Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory. |
| Q38475591 | Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates |
| Q35090146 | Expert systems in clinical microbiology |
| Q43248345 | Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium |
| Q38969959 | Extended-spectrum beta-lactamase- and carbapenemase-producing Enterobacteriaceae among Ethiopian children |
| Q34574557 | Extended-spectrum beta-lactamase-producing Shigella strains in Israel, 2000-2004. |
| Q43155418 | Extended-spectrum beta-lactamases in enterobacteria other than Escherichia coli and Klebsiella |
| Q24534999 | Extended-spectrum beta-lactamases: a clinical update |
| Q34159849 | Extended-spectrum ß-lactamases in gram negative bacteria |
| Q35558473 | Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control |
| Q36003062 | Genetic methods for detection of antimicrobial resistance |
| Q36261351 | High Heterogeneity of Escherichia coli Sequence Types Harbouring ESBL/AmpC Genes on IncI1 Plasmids in the Colombian Poultry Chain |
| Q35913952 | Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing |
| Q36424079 | Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases |
| Q46653069 | Prevalence of extended-spectrum beta-lactamases in Enterobacteriaceae, Pseudomonas and Stenotrophomonas as determined by the VITEK 2 and E test systems in a Kuwait teaching hospital |
| Q35590126 | Recent developments in beta lactamases and extended spectrum beta lactamases |
| Q35684566 | Sequence analysis of genes mediating extended-spectrum beta-lactamase (ESBL) production in isolates of Enterobacteriaceae in a Lagos Teaching Hospital, Nigeria |
| Q40004048 | TEM-187, a new extended-spectrum β-lactamase with weak activity in a Proteus mirabilis clinical strain |
| Q54418793 | The technical aspects and clinical significance of detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait. |
| Q36218305 | Transmission dynamics of extended-spectrum β-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting |
| Q35220822 | Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria |
| Q42130010 | Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. |
Search more.